Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
Posted in | Nanofluidics | Nanobusiness

Microfluidics Expands Partnership with Particle Sciences to Include Continuous Crystallization Capabilities

Published on July 8, 2010 at 9:02 AM

Microfluidics (OTCBB: MFLU), the exclusive global provider of Microfluidizer® high shear fluid processors, and Particle Sciences Inc. (PSI) , an integrated provider of drug development services, have expanded their partnership to include bottom-up nanoparticle creation and continuous manufacturing via High-Shear Microfluidics Reaction Technology™ (MRT).

“The pharmaceutical, chemical and energy industries continue to tell us that implementing a viable solution for continuous manufacturing is a strategic priority over the next few years,” said Bill Kober, Microfluidics Vice President of Sales for the Americas. “With High-Shear MRT, we believe we have developed a unique technology for crystallization and chemical reactions that has the potential to revolutionize large-scale production of drugs and chemicals worldwide. Due to our expanded collaboration with an innovative thought leader such as Particle Sciences, more pharmaceutical companies will be able to take advantage of the process consulting and product operation expertise required to optimize the commercial reward.”

Scientists from PSI continue to work alongside research engineers in the Microfluidics Technology Center on how to evaluate and establish process conditions for a wide variety of applications including inhalable drug, parenteral oncology treatments and photovoltaics.

“Leading pharmaceutical companies from around the world trust PSI to help them develop formulations that improve bioavailability, stability, target delivery and production scale efficiencies,” said Mark Mitchnick, CEO at Particle Sciences. “By adding High-Shear MRT to our portfolio of capabilities, we are better able to assist customers with aggressive nanomaterial goals and continuous manufacturing platform requirements. We are excited to offer these new possibilities as an integral part of our complete suite of solutions.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit